About Us
The PharmGKB is a pharmacogenomics knowledge resource that encompasses clinical information including clinical guidelines and drug labels, potentially clinically actionable gene-drug associations and genotype-phenotype relationships. PharmGKB collects, curates and disseminates knowledge about the impact of human genetic variation on drug responses through the following activities:
- Annotate genetic variants and gene-drug-disease relationships via literature review
- Summarize important pharmacogenomic genes, associations between genetic variants and drugs, and drug pathways
- Curate FDA drug labels containing pharmacogenomic information
- Enable consortia examining important questions in pharmacogenomics
- Curate and participate in writing pharmacogenomic-based drug dosing guidelines
- Contribute to clinical implementation projects for pharmacogenomics through collaborations
- Publish pharmacogenomic-based drug dosing guidelines, very important pharmacogene summaries and drug-centered pathways
- Display all information on the website and provide comprehensive downloads
Contact Us
Address:
Shriram Center for Bioengineering and
Chemical Engineering
443 Via Ortega, Room 213
BioE Altman Lab MC: 4245
Stanford, CA 94305
Email: feedback@pharmgkb.org(opens in new window)
Phone: (650) 725-0659

The Team











PharmGKB's scientific advisory board members are listed on our SAB page.